Concord Medical - Spon ADRCCM
13F holders, Q4 2025 (December 31)4holders
0new positions
0sold out
$3.72avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Concord Medical - Spon ADR (CCM) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were UBS Group AG ($3K), Morgan Stanley ($386) and SBI Securities Co., Ltd. ($15).
- Company
- Concord Medical - Spon ADR
- CUSIP
- 206277204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 36,985 shares sold, net −36,985 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| UBS Group AG | 0.00% | Reduce -97.7% | 863 | $3K |
| Morgan Stanley | 0.00% | No change | 100 | $386 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $15 |
| Bessemer Group Inc. | 0.00% | No change | 37 | $0 |
"% of holder's portfolio" is CCM's weight in each manager's 13F, not the share of Concord Medical - Spon ADR the manager owns.